Avenira Limited
ASX Code
AEV
Sector
Materials
Investor Centre
https://avenira.com/investors/asx-announcements
Website
https://avenira.com/
About
Avenira Limited (ASX:AEV) is an exploration company focused on gold assets in Western Australia and a phosphate asset in the Northern Territory with technology rights. Jundee South Gold Project Avenira’s Jundee South Gold Project in Western Australia comprises a tenement suite covering more than 720 km2 of the Yandal Greenstone Belt adjacent to several significant gold deposits, including the world class Jundee Mine (10Moz), Bronzewing (4Moz) and Darlot (3.5Moz) deposits. The Jundee South Project area is located within 3km of the operating Jundee Mine and covers more than 60km strike of highly prospective greenstone stratigraphy. The project area contains major regional structures interpreted to control gold mineralisation through the Yandal Greenstone Belt and contains a number of historically defined gold occurrences. The Yandal Greenstone belt is in the north eastern part of the Norseman-Wiluna gold belt in the Archaean Craton of Western Australia. Avenira has commenced a drilling program in September 2020 at Jundee South comprising Priority 1 and Priority 2 targets based on geophysical interpretation of data. Access is via a well-established road network, and given the number of operating mines in the area, there is ready access to accommodation and services. Wonarah Phosphate Project Avenira’s Wonarah Phosphate Project in the Northern Territory is considered to be one of Australia’s largest phosphate projects: – Measured Resources of 64.9 Mt @ 22.4% P2O5 – Indicated Resources of 133 Mt @ 21.1% P2O5 – Inferred Resource 352 Mt @ 21% P2O5 (15% cut-off) The project is close to infrastructure such as the Northern Gas Pipeline which runs through the project area. It is also adjacent to the national highway and a high quality water source. Novophos Licensing Agreement Avenira owns the exclusive Australian licence rights for an advanced super phosphoric acid production technology with Novophos Inc’ a private company in the United States.